abstract |
The present invention relates to a drug delivery system in the form of a water-soluble thin film (wafer), said drug delivery system comprising an estrogen receptor β (ER-β) selective agonist. The wafers of the present invention are suitable for treating, reducing or preventing a physical disease in a female mammal caused by insufficient internal levels of estrogen. |